136 related articles for article (PubMed ID: 10637478)
1. Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia.
Zhou M; Gu L; Abshire TC; Homans A; Billett AL; Yeager AM; Findley HW
Leukemia; 2000 Jan; 14(1):61-7. PubMed ID: 10637478
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and prognostic significance of murine double minute protein-2 overexpression and P53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Egypt J Immunol; 2008; 15(1):93-100. PubMed ID: 20306673
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of MDM2 in acute childhood lymphoblastic leukemia.
Gustafsson B; Stål O; Gustafsson B
Pediatr Hematol Oncol; 1998; 15(6):519-26. PubMed ID: 9842645
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene.
Zhou M; Yeager AM; Smith SD; Findley HW
Blood; 1995 Mar; 85(6):1608-14. PubMed ID: 7888679
[TBL] [Abstract][Full Text] [Related]
5. [Regulation of NF-kappaB/P65 by MDM2 in acute lymphoblastic leukemia in childhood].
Hu Q; Zhou MX; Liu SY; Zhang LQ; Liu AQ; Guo YJ; Song Y
Zhonghua Er Ke Za Zhi; 2003 Dec; 41(12):921-4. PubMed ID: 14723816
[TBL] [Abstract][Full Text] [Related]
6. High incidence of potential p53 inactivation in poor outcome childhood acute lymphoblastic leukemia at diagnosis.
Marks DI; Kurz BW; Link MP; Ng E; Shuster JJ; Lauer SJ; Brodsky I; Haines DS
Blood; 1996 Feb; 87(3):1155-61. PubMed ID: 8562942
[TBL] [Abstract][Full Text] [Related]
7. MDM2 induces NF-kappaB/p65 expression transcriptionally through Sp1-binding sites: a novel, p53-independent role of MDM2 in doxorubicin resistance in acute lymphoblastic leukemia.
Gu L; Findley HW; Zhou M
Blood; 2002 May; 99(9):3367-75. PubMed ID: 11964305
[TBL] [Abstract][Full Text] [Related]
8. Frequency and prognostic significance of murine double minute protein-2 overexpression and p53 gene mutations in childhood acute lymphoblastic leukemia.
Hendy OM; Elghannam DM; El-Sharnouby JA; Goda EF; El-Ashry R; Al-Tonbary Y
Hematology; 2009 Dec; 14(6):335-40. PubMed ID: 19941740
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia.
Marks DI; Kurz BW; Link MP; Ng E; Shuster JJ; Lauer SJ; Carroll D; Brodsky I; Haines DS
J Clin Oncol; 1997 Mar; 15(3):1158-62. PubMed ID: 9060559
[TBL] [Abstract][Full Text] [Related]
10. MDM2 and p53 in childhood acute lymphoblastic leukemia: higher expression in childhood leukemias with poor prognosis compared to long-term survivors.
Gustafsson B; Axelsson B; Gustafsson B; Christensson B; Winiarski J
Pediatr Hematol Oncol; 2001 Dec; 18(8):497-508. PubMed ID: 11764099
[TBL] [Abstract][Full Text] [Related]
11. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
Zhou M; Gu L; Findley HW; Jiang R; Woods WG
Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
[TBL] [Abstract][Full Text] [Related]
12. [Study on MDM2 and p53 gene proteins expression on acute leukemic cells and its correlation with chemotherapeutic efficacy].
Lin M; Liu Y; Jin J
Zhonghua Xue Ye Xue Za Zhi; 1998 Jul; 19(7):350-2. PubMed ID: 11189516
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of p53 and MDM2 proteins in hematological malignancies.
Koníková E; Kusenda J
Neoplasma; 2003; 50(1):31-40. PubMed ID: 12687276
[TBL] [Abstract][Full Text] [Related]
14. Cellular expression of MDM2 and p53 in childhood leukemias with poor prognosis.
Gustafsson B; Christenson B; Hjalmar V; Winiarski J
Med Pediatr Oncol; 2000 Feb; 34(2):117-24. PubMed ID: 10657873
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous assessment of p53 and MDM2 expression in leukemic cells in response to initial prednisone therapy in children with acute lymphoblastic leukemia.
Ociepa T; Maloney E; Kamieńska E; Wysocki M; Kurylak A; Matysiak M; Urasiński T; Urasińska E; Domagała W
Pol J Pathol; 2010; 61(4):199-205. PubMed ID: 21290342
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of WT1 gene expression in regulation of P53 and MDM2 proteins function in acute lymphoblastic leukemia].
Bartkowiak J; Wójcik I; Stankiewicz W
Pol Merkur Lekarski; 2001 Nov; 11(65):402-5. PubMed ID: 11852808
[TBL] [Abstract][Full Text] [Related]
18. p53 gene status and chemosensitivity of childhood acute lymphoblastic leukemia cells to adriamycin.
Lam V; McPherson JP; Salmena L; Lees J; Chu W; Sexsmith E; Hedley DW; Freedman MH; Reed JC; Malkin D; Goldenberg GJ
Leuk Res; 1999 Oct; 23(10):871-80. PubMed ID: 10573131
[TBL] [Abstract][Full Text] [Related]
19. The expression pattern of Bcl11a, Mdm2 and Pten genes in B-cell acute lymphoblastic leukemia.
Xu L; Wu H; Wu X; Li Y; He D
Asia Pac J Clin Oncol; 2018 Apr; 14(2):e124-e128. PubMed ID: 28544358
[TBL] [Abstract][Full Text] [Related]
20. MDM2 oncogene as a target for cancer therapy: An antisense approach.
Wang H; Zeng X; Oliver P; Le LP; Chen J; Chen L; Zhou W; Agrawal S; Zhang R
Int J Oncol; 1999 Oct; 15(4):653-60. PubMed ID: 10493945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]